Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion type Assertion NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_head.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion description "[Moreover, the detection of high-level expression of minimally phosphorylated epidermal growth factor receptor (EGFR) in both TT and MZ-CRC-1 cells, together with our data on the effects of EGF stimulation on the proteomic profiles and the response to Gefitinib treatment, suggest the relevance of EGFR signaling in these cell lines, especially since analysis of 14 archival MTC specimens revealed EGFR mRNA expression in all samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_provenance.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion evidence source_evidence_literature NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_provenance.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion SIO_000772 18756447 NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_provenance.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion wasDerivedFrom befree-20140225 NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_provenance.
- NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_assertion wasGeneratedBy ECO_0000203 NP880617.RAD-wOjJMbVM9LEkZ6TEQf7Qj0H0U0Q9vARyE5_FI3Q4c130_provenance.